Lanreotide diTFA

SKU: orb1942817

Description

Lanreotide diTFA (BIM 23014) is a somatostatin analog used in cancer research, particularly for studying carcinoid syndrome. It demonstrates antitumor properties in vitro and has been evaluated in vivo for its ability to inhibit hormone secretion and tumor growth in neuroendocrine models.

Research Area

Pharmacology & Drug Discovery

Key Properties

• Target: Somatostatin
• CAS Number: 1024499-83-9
• MW: 1324.37
• Formula: C₅₈H₇₁F₆N₁₁O₁₄S₂
• SMILES: OC(C(F)(F)F)=O.O=C([C@@H](NC([C@H](CSSC[C@H](NC([C@@H](NC([C@@H](NC1=O)CCCCN)=O)C(C)C)=O)C(N[C@H](C(N)=O)[C@H](O)C)=O)NC([C@H](N)CC2=CC3=C(C=CC=C3)C=C2)=O)=O)CC4=CC=C(C=C4)O)N[C@@H]1CC5=CNC6=CC=CC=C56.OC(C(F)(F)F)=O

Storage & Handling

• Storage: -20°C
• Expiration Date: 12 months from date of receipt.
• Disclaimer: For research use only

Compound Identifiers

PubChem CID

164886679